Trials by Condition
Showing 1 - 20 of 31 trials – Showing only trials currently accepting patients
-
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
Stanford is currently accepting patients for this trial. -
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
Stanford is currently accepting patients for this trial. -
To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma
Stanford is currently accepting patients for this trial. -
Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma
Stanford is currently accepting patients for this trial. -
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients
Stanford is currently accepting patients for this trial. -
Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia
Stanford is currently accepting patients for this trial. -
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Stanford is currently accepting patients for this trial. -
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Stanford is currently accepting patients for this trial. -
Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia
Stanford is currently accepting patients for this trial. -
Safety of Myeloablative Conditioning, Orca-T, and Allogeneic, Donor-Derived CD19/CD22-CAR (Chimeric Antigen Receptor) T Cells in Adults With B-cell Acute Lymphoblastic Leukemia (ALL)
Stanford is currently accepting patients for this trial. -
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
Stanford is currently accepting patients for this trial. -
Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)
Stanford is currently accepting patients for this trial. -
Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
Stanford is currently accepting patients for this trial. -
IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML
Stanford is currently accepting patients for this trial. -
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Stanford is currently accepting patients for this trial. -
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Stanford is currently accepting patients for this trial. -
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
Stanford is currently accepting patients for this trial. -
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Stanford is currently accepting patients for this trial. -
Feasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid Leukemia
Stanford is currently accepting patients for this trial. -
Feasibility Neurocognitive Outcome After Transplant
Stanford is currently accepting patients for this trial.